Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Sees Large Growth in Short Interest

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 15,707 shares, a growth of 80.4% from the December 31st total of 8,707 shares. Based on an average daily volume of 12,731 shares, the days-to-cover ratio is presently 1.2 days. Based on an average daily volume of 12,731 shares, the days-to-cover ratio is presently 1.2 days.

Coeptis Therapeutics Price Performance

Shares of COEPW stock traded up $0.00 during trading hours on Friday, reaching $0.01. The company had a trading volume of 1,871 shares, compared to its average volume of 18,442. Coeptis Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.05. The stock’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.02.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.